Davenport & Co’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,031
| Closed | -$200K | – | 1139 |
|
|
2024
Q3 | $200K | Buy |
+3,031
| New | +$200K | ﹤0.01% | 1083 |
|
|
2024
Q1 | – | Sell |
-2,830
| Closed | -$216K | – | 1088 |
|
|
2023
Q4 | $216K | Buy |
+2,830
| New | +$216K | ﹤0.01% | 970 |
|
|
2023
Q3 | – | Sell |
-2,889
| Closed | -$273K | – | 1041 |
|
|
2023
Q2 | $273K | Buy |
2,889
+42
| +1% | +$3.96K | ﹤0.01% | 904 |
|
|
2023
Q1 | $236K | Sell |
2,847
-567
| -17% | -$46.9K | ﹤0.01% | 915 |
|
|
2022
Q4 | $255K | Sell |
3,414
-2,986
| -47% | -$223K | ﹤0.01% | 850 |
|
|
2022
Q3 | $529K | Sell |
6,400
-584
| -8% | -$48.3K | ﹤0.01% | 639 |
|
|
2022
Q2 | $664K | Sell |
6,984
-482
| -6% | -$45.8K | 0.01% | 587 |
|
|
2022
Q1 | $879K | Buy |
7,466
+416
| +6% | +$49K | 0.01% | 573 |
|
|
2021
Q4 | $913K | Buy |
7,050
+240
| +4% | +$31.1K | 0.01% | 572 |
|
|
2021
Q3 | $771K | Buy |
6,810
+442
| +7% | +$50K | 0.01% | 602 |
|
|
2021
Q2 | $660K | Buy |
6,368
+3,639
| +133% | +$377K | 0.01% | 573 |
|
|
2021
Q1 | $228K | Sell |
2,729
-400
| -13% | -$33.4K | ﹤0.01% | 730 |
|
|
2020
Q4 | $285K | Hold |
3,129
| – | – | ﹤0.01% | 654 |
|
|
2020
Q3 | $250K | Sell |
3,129
-846
| -21% | -$67.6K | ﹤0.01% | 625 |
|
|
2020
Q2 | $275K | Sell |
3,975
-75
| -2% | -$5.19K | ﹤0.01% | 569 |
|
|
2020
Q1 | $255K | Sell |
4,050
-468
| -10% | -$29.5K | ﹤0.01% | 531 |
|
|
2019
Q4 | $351K | Sell |
4,518
-282
| -6% | -$21.9K | ﹤0.01% | 552 |
|
|
2019
Q3 | $296K | Hold |
4,800
| – | – | ﹤0.01% | 565 |
|
|
2019
Q2 | $296K | Hold |
4,800
| – | – | ﹤0.01% | 569 |
|
|
2019
Q1 | $306K | Sell |
4,800
-90
| -2% | -$5.74K | ﹤0.01% | 533 |
|
|
2018
Q4 | $250K | Sell |
4,890
-300
| -6% | -$15.3K | ﹤0.01% | 552 |
|
|
2018
Q3 | $301K | Buy |
5,190
+210
| +4% | +$12.2K | ﹤0.01% | 551 |
|
|
2018
Q2 | $242K | Buy |
+4,980
| New | +$242K | ﹤0.01% | 606 |
|